华仁药业
(300110)
| 流通市值：39.20亿 | | | 总市值：39.25亿 |
| 流通股本：11.81亿 | | | 总股本：11.82亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 222,890,633.82 | 211,064,591.05 | 181,984,201.47 | 163,813,254.9 |
| 应收票据及应收账款 | 513,740,682.17 | 519,505,843.27 | 537,471,940.05 | 529,961,276.84 |
| 其中：应收票据 | 6,645,456.63 | 6,688,247.26 | 10,281,791.52 | 3,550,592.27 |
| 应收账款 | 507,095,225.54 | 512,817,596.01 | 527,190,148.53 | 526,410,684.57 |
| 应收款项融资 | 85,238,461.85 | 77,120,233.91 | 69,622,083.25 | 98,485,665.29 |
| 预付款项 | 33,075,466.47 | 27,476,929.01 | 31,208,317.51 | 20,286,124.35 |
| 其他应收款合计 | 37,067,111.84 | 35,088,306.8 | 45,027,438.34 | 34,706,613.75 |
| 存货 | 252,561,995.35 | 279,057,706.19 | 281,481,226.88 | 318,237,397.12 |
| 其他流动资产 | 17,807,964.58 | 19,766,034.3 | 23,125,808.13 | 19,488,277.34 |
| 流动资产合计 | 1,162,382,316.08 | 1,169,079,644.53 | 1,169,921,015.63 | 1,184,978,609.59 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 15,984,624 | 15,984,624 | 15,984,624 | 15,984,624 |
| 其他非流动金融资产 | 0 | - | - | 0 |
| 投资性房地产 | 8,883,770.4 | 8,955,830.94 | 9,027,891.48 | 9,099,952.02 |
| 固定资产 | 967,329,501.69 | 978,939,852.08 | 1,013,026,006.03 | 1,013,876,010.17 |
| 在建工程 | 111,395,219.1 | 103,695,060.28 | 85,119,270.14 | 61,897,249 |
| 生产性生物资产 | 0 | - | - | 0 |
| 油气资产 | 0 | - | - | 0 |
| 使用权资产 | 1,233,084.74 | 69,684.53 | 174,211.32 | 278,738.12 |
| 无形资产 | 288,914,895.02 | 290,915,232.25 | 301,660,877.4 | 301,702,760.5 |
| 开发支出 | 2,811,112.22 | 6,194,146.11 | 6,160,665.71 | 5,924,582.31 |
| 商誉 | 732,611,620.38 | 732,611,620.38 | 732,611,620.38 | 732,611,620.38 |
| 长期待摊费用 | 8,997,956.78 | 9,923,784.06 | 9,296,479.5 | 12,203,059.98 |
| 递延所得税资产 | 59,484,397.43 | 59,341,627.36 | 57,223,085.87 | 57,186,729.9 |
| 其他非流动资产 | 36,780,209.77 | 49,252,690.9 | 49,958,386.92 | 32,376,143.42 |
| 非流动资产合计 | 2,234,426,391.53 | 2,255,884,152.89 | 2,280,243,118.75 | 2,243,141,469.8 |
| 资产总计 | 3,396,808,707.61 | 3,424,963,797.42 | 3,450,164,134.38 | 3,428,120,079.39 |
| 流动负债: | | | | |
| 短期借款 | 485,932,876.71 | 503,017,390.41 | 488,973,603.47 | 424,409,222.57 |
| 应付票据及应付账款 | 115,500,434.06 | 120,224,704.15 | 121,898,794.15 | 147,354,912.89 |
| 应付账款 | 115,500,434.06 | 120,224,704.15 | 121,898,794.15 | 147,354,912.89 |
| 预收款项 | 0 | - | - | 0 |
| 合同负债 | 33,122,072.58 | 32,683,097.6 | 29,739,775.81 | 32,463,991.71 |
| 应付职工薪酬 | 17,346,403.11 | 16,560,315.64 | 21,240,645.5 | 17,055,717.7 |
| 应交税费 | 15,871,518.84 | 12,007,082.8 | 22,034,331.04 | 21,201,790.71 |
| 其他应付款合计 | 299,101,401.93 | 283,262,598.97 | 210,507,212.71 | 208,241,812.09 |
| 一年内到期的非流动负债 | 591,492,562.4 | 613,252,562.4 | 725,885,124.8 | 692,952,562.4 |
| 其他流动负债 | 4,305,869.43 | 2,960,828.13 | 3,866,170.85 | 2,951,861.98 |
| 流动负债合计 | 1,562,673,139.06 | 1,583,968,580.1 | 1,624,145,658.33 | 1,546,631,872.05 |
| 非流动负债: | | | | |
| 长期借款 | 366,131,145 | 385,945,250 | 392,825,250 | 464,080,000 |
| 租赁负债 | 961,926.04 | - | - | - |
| 递延收益 | 131,559.37 | 131,559.37 | 131,559.37 | 131,559.37 |
| 递延所得税负债 | 41,063,477.64 | 41,825,087.98 | 42,586,698.29 | 43,348,308.62 |
| 非流动负债合计 | 408,288,108.05 | 427,901,897.35 | 435,543,507.66 | 507,559,867.99 |
| 负债合计 | 1,970,961,247.11 | 2,011,870,477.45 | 2,059,689,165.99 | 2,054,191,740.04 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 |
| 资本公积 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 |
| 盈余公积 | 90,616,259.13 | 90,528,384.95 | 90,528,384.95 | 90,528,384.95 |
| 未分配利润 | -445,507,273.74 | -462,666,310.24 | -483,970,743.77 | -499,999,193.41 |
| 归属于母公司股东权益合计 | 1,355,366,082.86 | 1,338,119,172.18 | 1,316,814,738.65 | 1,300,786,289.01 |
| 少数股东权益 | 70,481,377.64 | 74,974,147.79 | 73,660,229.74 | 73,142,050.34 |
| 股东权益合计 | 1,425,847,460.5 | 1,413,093,319.97 | 1,390,474,968.39 | 1,373,928,339.35 |
| 负债和股东权益合计 | 3,396,808,707.61 | 3,424,963,797.42 | 3,450,164,134.38 | 3,428,120,079.39 |
| 公告日期 | 2025-10-30 | 2025-08-16 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |